Amundi Outset Medical, Inc. Transaction History

Amundi

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$10.52 - $20.68 $59,238 - $116,449	5,631 Added 5.04%	117,273 $1.28 Million
Q2 2023 Aug 14, 2023	SELL	$17.18 - $23.76 $79,543 - $110,008	-4,630 Reduced 3.98%	111,642 $2.44 Million
Q1 2023 May 15, 2023	SELL	$18.25 - $30.26 $9,855 - $16,340	-540 Reduced 0.46%	116,272 $2.14 Million
Q4 2022 Feb 14, 2023	SELL	$12.36 - $26.41 $85,024 - $181,674	-6,879 Reduced 5.56%	116,812 $3.02 Million
Q3 2022 Nov 14, 2022	BUY	$14.67 - $21.7 $691,734 - $1.02 Million	47,153 Added 61.61%	123,691 $2.04 Million
Q2 2022 Aug 15, 2022	BUY	$13.46 - $48.16 $1.03 Million - $3.69 Million	76,538 New	76,538 $1.24 Million

19.9M

66.8K

60.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.